Table 1.
Characteristics of the study cohort.
| CTR | SSc | N | |
|---|---|---|---|
| Sex [n female subj.] | 29 | 63 | 44/78 |
| Age [yrs] | 57 (48-63) | 61 (53-67) | 44/78 |
| Calcium [mmol/l] | 2.34 (2.30-2.41) | 2.36 (2.32-2.42) | 33/70 |
| Phosphate [mmo/l] | 0.93 (0.86-1.06) | 1.10 (1.00-1.20)*** | 32/71 |
| Magnesium [mmol/l] | 0.86 (0.82-089) | 0.87 (0.81-0.90) | 24/34 |
| Zinc [ug/l] | 857.6 (747.2-926.7) | 742.2 (661.9-848.2)** | 43/77 |
| eGFR [ml/min/1.73m2] | 97.7 (89.0-104.8) | 95.3 (80.1-102.1) | 42/77 |
| intact FGF23 [pg/ml] | 5.84 (3.65-10.55) | 7.65 (3.79-18.08) | 44/76 |
| 1-84 PTH [pg/ml] | 12.07 (7.77-21.63) | 17.12 (10.46-27.01)* | 44/77 |
Sex (shown as n of female subjects) as well as median and interquartile range of age, eGFR, serum levels of calcium, phosphate, magnesium, intact FGF23 and 1-84 PTH in controls and SSc patients. *,**, *** indicates p< 0.05, p<0.01, p<0.001 vs. CTR.